Clinical Trials

Burlington Medical Associates and Gary I. Portnay, M.D., along with several other providers, are involved in several clinical trials and are currently enrolling participants.

Clinical trials are entirely voluntary and subjects may withdraw consent at anytime, for any reason. Currently, we have open enrollment for the following clinical trials:

ALTITUDE TRIAL

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Determine Whether, in Patients With Type 2 Diabetes at High Risk for Cardiovascular and Renal Events, Aliskiren, on Top of Conventional Treatment, Reduces Cardiovascular and Renal Morbidity and Mortality.

LANCET TRIAL

A Randomized Clinical Trial of LantusÒ for C – reactive Protein Reduction in Early Treatment of Type 2 Diabetes.

PRECISION TRIAL

A Randomized, Double-Blind, Parallel-Group Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients With or at High Risk for Cardiovascular Disease Comparing Celecoxib with Naproxen and Ibuprofen.

ROCHE

A Randomized, Double-Blind, Placebo-Controlled study assessing the Effect of RO4607381 on Cardiovascular Mortality and Morbidity in Clinically Stable Patients with a Recent Acute Coronary Syndome.

To inquire if you are eligible to participate in one of these clinical trials, please contact:

Lori Brazee
Clinical Research Coordinator
Office # 781-505-8710
Email : lbrazee@pchi.partners.org